Monoclonal antibodies against human interleukin-4 and hybridomas

Chemistry: molecular biology and microbiology – Spore forming or isolating process

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

530387, 530413, 935104, 935108, 935110, 436518, 435 7, C07K 1528, C12N 520, G01N 33543, G01N 33535

Patent

active

050413813

ABSTRACT:
Monoclonal antibodies are provided which are specific for human interleukin-4. Kits and methods are also provided for detecting, measuring and immunopurifying human interleukin-4.

REFERENCES:
patent: 4431739 (1984-02-01), Riggs
Sahasrabuddhe et al., pp. 463-473 in "Immune Regulation by Characterized Polypeptides U.C.L.A. Symp. Mol. & Cell Biology New Series" vol. 41 Alan R. Uss Inc. 5/87 Goldstein et al. Eds.
Kipps et al., p. 108.1-108.9 in Handbook of Expt'l Immunology vol. 4.
Weir et al., Eds., Blackwell Sci. Publ. 1986.
Ohara et al., Nature 315: 333-336 1985.
Yokota et al. PNAS 83:5894-5898, 1986.
Mehta et al., J. Immunology 135: 3298-3302, 1985.
Morrison Science 229: 1202, 1985.
Williams et al., pp. 22.1-22.24 in Handbook of Exptl. Immunology vol. 1, Weir et al. Eds. Blackwell Sci. Publ. 1986.
Howard et al., Immunol. Rev. 78: 185 1984.
Sharma et al., Science, vol. 235, pp. 1489-1492 (1987).

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Monoclonal antibodies against human interleukin-4 and hybridomas does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Monoclonal antibodies against human interleukin-4 and hybridomas, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Monoclonal antibodies against human interleukin-4 and hybridomas will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-1007617

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.